A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1031
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IPMN
Long Form : intraductal papillary mucinous neoplasm
No. Year Title Co-occurring Abbreviation
2021 A case of endoscopic ultrasound-guided hepaticogastrostomy for obstructive jaundice caused by intraductal papillary mucinous neoplasm-associated pancreatobiliary fistula. EUS, HGS
2021 A case of intraductal papillary mucinous neoplasm developing in the native pancreas after pancreas transplantation treated by total pancreatectomy. TP
2021 A case of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas derived from an intraductal papillary mucinous neoplasm. GCT, UCOGC
2021 A case report of gallbladder cancer and pancreas cystic neoplasm associated with pancreaticobiliary maljunction. MUC6, PBM
2021 A meta-analysis: incidental intraductal papillary mucinous neoplasm and extra-pancreatic malignancy. EPM, OR
2021 A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study. AJCC, TNM
2021 A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions. MCN
2021 ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous Neoplasms. PDAC, SHR
2021 Artificial neural networks versus LASSO regression for the prediction of long-term survival after surgery for invasive IPMN of the pancreas. ANN, SEER
10  2021 Carbohydrate Antigen 19-9 Is an Invasive Malignancy Preoperative Prognostic Factor for Intraductal Papillary Mucinous Neoplasms. CA, OS
11  2021 Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm? MiNEN, NET, NGS
12  2021 Coexisting Type 1 Autoimmune Pancreatitis and Mixed-type Intraductal Papillary Mucinous Neoplasm. AIP
13  2021 Colloid carcinoma derived from intraductal papillary mucinous neoplasm of the pancreatic head with calcification: A case report and literature review. IPMC, UICC
14  2021 Comparison of Preoperative Evaluation with the Pathological Report in Intraductal Papillary Mucinous Neoplasms: A Single-Center Experience. EEBGPCN, FCG, PCN
15  2021 Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreas. AUC, MPD
16  2021 Computer-aided differentiates benign from malignant IPMN and MCN with a novel feature selection algorithm. AUC, CAD, MCN, SVM
17  2021 Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct. IPNB
18  2021 Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts. HGD, HR, IOPN, mAb, MCN, PanNET, PC
19  2021 Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study. AUC
20  2021 Diagnostic Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Characterization of Intraductal Papillary Mucinous Neoplasms: An Updated Systematic Review and Meta-analysis. CI, CT, FDG, LR, PET
21  2021 Ductal Dilatation of ≥5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases. HGD, IC, MPD
22  2021 External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model. BD, DCA
23  2021 Hemosuccus Pancreaticus Due to the Rupture of a Pseudoaneurysm That Developed in an Intraductal Papillary Mucinous Neoplasm. ---
24  2021 Humoral Predictors of Malignancy in IPMN: A Review of the Literature. CA19-9, CEA, miRNA
25  2021 Indication for resection and possibility of observation for intraductal papillary mucinous neoplasm with high-risk stigmata. HRS, MPD, WF
26  2021 Indocyanine green fluorescence to ensure perfusion in middle segment-preserving pancreatectomy: a case report. ICG, MSPP
27  2021 Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. IPMC, PDAC
28  2021 Intraductal Papillary Mucinous Neoplasm of the Pancreas Arising in a Patient With Limited Cutaneous Systemic Sclerosis. lcSS, SS
29  2021 Intraductal papillary mucinous neoplasm of the pancreas: Cytomorphology, imaging, molecular profile, and prognosis. FNA
30  2021 Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI. MPD
31  2021 Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Review of Their Genetic Characteristics and Mouse Models. PDAC
32  2021 Intraductal tubulopapillary neoplasms of the pancreas and biliary tract: The black swan of hepatobiliary surgery. ITPNs
33  2021 IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy. ---
34  2021 Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties. ---
35  2021 Laparoscopic distal pancreatectomy for intraductal papillary mucinous neoplasm-associated pancreatic cancer: A case report. ---
36  2021 Long-term outcome after EUS-guided radiofrequency ablation: Prospective results in pancreatic neuroendocrine tumors and pancreatic cystic neoplasms. EUS-RFA, NETs, PCNs, WF/HRS
37  2021 Magnetic resonance imaging-derived fat fraction predicts risk of malignancy in intraductal papillary mucinous neoplasm. BMI, DM
38  2021 Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm. CEA, DSS, HGD, IPMC, OR, RFS
39  2021 Micro-RNA Analysis of Pancreatic Cyst Fluid for Diagnosing Malignant Transformation of Intraductal Papillary Mucinous Neoplasm by Comparing Intraductal Papillary Mucinous Adenoma and Carcinoma. IPMA, IPMC, miRNAs
40  2021 MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma. miRNAs, PDAC
41  2021 MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing. INV, miRNAs
42  2021 MNX1-HNF1B axis is indispensable for intraductal papillary mucinous neoplasm lineages. PDAC
43  2021 Mucinous Pancreatic Cysts: Comparison of Cyst Size and Location in Certain Mucinous Cyst Subgroups. AUROC, CT, HR, HUN, LR, MCN, non-MD, NPV, PDAC
44  2021 Multi-institutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas. EUS-FNA
45  2021 Narrative review of intraductal papillary mucinous neoplasms: pathogenesis, diagnosis, and treatment of a true precancerous lesion. ---
46  2021 Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms. ---
47  2021 Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma. inv-IPMN, mOS, OS, PDAC
48  2021 Pancreatic cancer secondary to intraductal papillary mucinous neoplasm with collision between gastric cancer and B-cell lymphoma: A case report. CA, DLBCL, EUS
49  2021 Pancreatic cystic neoplasms: a review of current recommendations for surveillance and management. AGA, cNET, IAP, MCN, PCN, SCN
50  2021 Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival. PDAC
51  2021 Pancreatic Intraductal Papillary Mucinous Neoplasm with Hyaline Globules (Thanatosomes): Report of Two Cases. ---
52  2021 Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report. PMC
53  2021 Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas. ---
54  2021 PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions. ADM, FAO, KD, OXPHOS, PanIN, PDAC, PPL, TMA
55  2021 Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma. BPDs, MPD, PanIN, PDAC
56  2021 Prevalence and Risk Factors for Intraductal Papillary Mucinous Neoplasm in Patients With Chronic Kidney Disease: A Single-Center Case-Control Study. CKD
57  2021 Recurrent pancreatitis due to intraductal papillary mucinous neoplasm in a young adult. ---
58  2021 Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies. BD, MD, RAP
59  2021 Should Contrast-Enhanced Harmonic Endoscopic Ultrasound Be Incorporated into the International Consensus Guidelines to Determine the Appropriate Treatment of Intraductal Papillary Mucinous Neoplasm? CH-EUS, ICG, NPV, PPV, Se, Sp, WF
60  2021 Should non-invasive diffuse main-duct intraductal papillary mucinous neoplasms be treated with total pancreatectomy? MD
61  2021 Sites of Distant Metastases and Cancer-Specific Survival in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma: A Study of 1,178 Patients. CI, CSS, HR, SEER
62  2021 Supplemental 18F-FDG-PET/CT for Detection of Malignant Transformation of IPMN-A Model-Based Cost-Effectiveness Analysis. QALY
63  2021 Surgical outcomes are hampered after endoscopic ultrasonography-guided ethanol lavage and/or Taxol injection in cystic lesions of the pancreas. EUS-ELTI
64  2021 Surgical resection for intraductal papillary mucinous neoplasm in the older population. MSKFI
65  2021 Synchronous Pancreatic Tumours: Intraductal Papillary Mucinous Neoplasm with Pancreatic Ductal Adenocarcinoma and Neuroendocrine Tumour: A Case Presentation and Review of Literature. NET
66  2021 The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm. ALI, NLR, PLR
67  2021 The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients. CNVs, PDAC, SPT
68  2021 The outcome of laparoscopic pancreatoduodenectomy is improved with patient selection and the learning curve. LPD, POPF
69  2021 The prognostic roles of the prognostic nutritional index in patients with intraductal papillary mucinous neoplasm. CA, LNM, OR, PNI
70  2021 Total pancreatectomy for pancreatic remnant carcinoma five years after pancreaticoduodenectomy: Report a case. ---
71  2021 Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia. AFL, CAFs, MCN, PanIN, PDAC, TME
72  2021 Utility of endoscopic transpapillary pancreatic cyst drainage for intraductal papillary mucinous neoplasm infection. ---
73  2021 Utility of multiphase contrast enhancement patterns on CEH-EUS for the differential diagnosis of IPMN-derived and conventional pancreatic cancer. CEH-EUS, IPMC, PC, PDAC
74  2021 Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays. PDAC
75  2021 [A Case of Intraductal Papillary Mucinous Carcinoma of the Pancreas Extending Widely within the Pancreas Resected by Total Pancreatectomy]. IPMC
76  2021 [All you should know about intraductal papillary mucinous neoplasm (IPMN)]. PDAC
77  2021 [Combination of intraductal papillary mucinous neoplasm with other cystic pancreatic tumors]. ---
78  2021 [Indications for the surgical management of pancreatic neoplasms]. MCN, SCN, SPN
79  2021 [Intraductal neoplasms of the pancreas]. IOPN, ITPN, PanINs
80  2021 [Measurement of PODXL and SCGB1D2 for detecting intraductal papillary mucinous neoplasm]. AUC, IPMA, IPMC
81  2020 A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study. ANN, CECT, MCN, PCN, RF, SCA, SVM
82  2020 A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia. A1AT, ApoA1, DBP
83  2020 A retrospective study of histological outcome for IPMN after surgery in Lausanne, Switzerland: A case series. CA19-9
84  2020 Acute pancreatitis in intraductal papillary mucinous neoplasms correlates with pancreatic volume and epithelial subtypes. AP
85  2020 Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review. PDAC
86  2020 CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype. IOPN
87  2020 Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm". PDAC
88  2020 Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm. 3D-MRCP, cMRI, MPD, MRI
89  2020 Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation. DSS, HRS, MPD, OS
90  2020 Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm. ---
91  2020 CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. AUC, EVC, Se, SPE, TC
92  2020 Decreased CT-number in the pancreatic parenchyma is a reliable imaging biomarker of the presence of malignancies in patients with high-risk intraductal papillary mucinous neoplasm. CT, PI, PS
93  2020 Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance. AUC, cfDNA, CI, dPCR, HBB, HR, MT-ND1, PDA
94  2020 Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytologic Evaluation of Intraductal Papillary Mucinous Neoplasm and Mucinous Cystic Neoplasms of Pancreas. AC, BN, HGD, LGD/MD, MCLs, MCN, ND, PSC
95  2020 Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey. CPNs
96  2020 Evidence of a common cell origin in a case of pancreatic mixed intraductal papillary mucinous neoplasm-neuroendocrine tumor. MiNEN, NET
97  2020 Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm. IHC, IOPN, ITPN, MMR, MSI
98  2020 Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status: Continuously Increasing Risk of Recurrence Even After Curative Resection Suggesting Necessity of Lifetime Surveillance. HGD, LGD
99  2020 How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression. ---
100  2020 Hyalinized stroma is a characteristic feature of pancreatic intraductal oncocytic papillary neoplasm: An immunohistochemical study. HS, IOPN, IPMN-I